Challenges and Opportunities in Using Residual Newborn Screening Samples for Translational Research
Workshop Summary
-
- $16.99
-
- $16.99
Publisher Description
Newborn screening samples are used to test more than 4 million infants each year for life-threatening diseases that are treatable if found at birth. These specimens also represent a potentially invaluable resource for public health and biomedical research. The IOM held a workshop to examine issues surrounding the use of residual specimens for translational research.
Expanding Newborn Screening: Process, Policy, And Priorities.
2008
Conducting Biosocial Surveys
2010
Every Child Is Priceless: Debating Effective Newborn Screening Policy (Letter to the Editor)
2009
Research Ethics
2006
Protecting Data Privacy in Health Services Research
2000
Issues in Returning Individual Results from Genome Research Using Population-Based Banked Specimens, with a Focus on the National Health and Nutrition Examination Survey
2014